Optimizerx CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

20 Mar 2025

OPRX

10-K: OptimizeRx Reports Increased Revenue but Faces Net Loss in 2024; Names New CEO

OptimizeRx's 2024 10-K filing reveals a revenue increase driven by acquisitions and DAAP sales, but also highlights a net loss and ongoing efforts to improve financial controls.

NASDAQ

15 Apr 2024

OPRX

Optimizerx CORP

10-K: OptimizeRx Reports 15% Revenue Increase in 2023, Driven by Strategic Acquisitions and AI Platform Growth

OptimizeRx's 2023 annual report highlights a 15% revenue increase to $71.5 million, fueled by strategic acquisitions and the expansion of its AI-powered platform.